Skip to main content
Clinical Trials/NCT04525625
NCT04525625
Recruiting
Not Applicable

Risk Factors for Acute Kidney Injury in Critically Ill Patients With Acute-on-Chronic Liver Failure

Institutul Clinic Fundeni1 site in 1 country200 target enrollmentFebruary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Kidney Injury
Sponsor
Institutul Clinic Fundeni
Enrollment
200
Locations
1
Primary Endpoint
AKI
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Acute kidney injury (AKI) is one of the most important factors associated with increased mortality in patients with acute-on-chronic liver failure (AoCLF). Early identification and treatment of this subgroup of patients may improve survival and decrease ICU length of stay. As kidney ischemia is one of the main mechanisms responsible for AKI in AoCLF, an increase in urinary to arterial partial pressure of oxygen may help in the early diagnosis of renal failure. For this arterial and urinary oxygen pressure will be measured at ICU admission, on day 1 and day 3 of ICU stay. Diagnosis of AKI within the first 28 days after ICU admission will be recorded

Registry
clinicaltrials.gov
Start Date
February 1, 2021
End Date
December 31, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Popescu Mihai

clinical professor

Institutul Clinic Fundeni

Eligibility Criteria

Inclusion Criteria

  • patients admitted to the ICU for acute-on-chronic liver failure

Exclusion Criteria

  • pre-existing renal disease
  • urine output\<200 mL/day
  • death within the first 24 hours after ICU admission
  • emergency liver transplantation within the follow-up period (28 days)

Outcomes

Primary Outcomes

AKI

Time Frame: 28 days after ICU admission

incidence (%) of AKI in patients with AoCLF as defined by Acute Kidney Injury Network guidelines

Secondary Outcomes

  • arterial to urinary oxygen gradient(ICU admission, ICU day 1 and ICU dy 3)
  • mortality(28-days)

Study Sites (1)

Loading locations...

Similar Trials